Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25727
Abstract: Ileal neuroendocrine tumors (i‐NETs) frequently metastasize to mesenteric lymph nodes and the liver. Regional lymphadenopathy is associated with desmoplasia of the mesentery forming a large mesenteric mass (LMM). Although the latest American Joint Committee on… read more here.
Keywords: large mesenteric; neuroendocrine tumors; mesenteric mass; prognostic impact ... See more keywords
Management of Ileal Neuroendocrine Tumors with Liver Metastases
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-019-04309-7
Abstract: Purpose Assessment of treating metastatic ileal neuroendocrine tumors (NETs) with complete resection of primary tumor, nodal and liver metastases, plus administration of long-acting somatostatin analogues (SSAs). Methods A prospective database was queried for patients with… read more here.
Keywords: ileal pancreatic; pathology; neuroendocrine tumors; liver metastases ... See more keywords
IGF2 drives formation of ileal neuroendocrine tumors in patients and mice.
Sign Up to like & getrecommendations! Published in 2020 at "Endocrine-related cancer"
DOI: 10.1530/erc-19-0505
Abstract: By the strictest of definitions, a genetic driver of tumorigenesis should fulfill two criteria: it should be altered in a high percentage of patient tumors, and it should also be able to cause the same… read more here.
Keywords: genetic background; neuroendocrine tumors; ileal neuroendocrine; rt2 mice ... See more keywords